Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2023 1
2024 9
2025 7
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.
Shen CJ, Chen HC, Lin CL, Thakur A, Onuku R, Chen IC, Li HY, Chang KY, Chuang JY, Yang WB, Lin HY, Shen YR, Liou JP, Chang WC, Hsu TI. Shen CJ, et al. Among authors: chen hc. Adv Sci (Weinh). 2025 Oct;12(38):e06336. doi: 10.1002/advs.202506336. Epub 2025 Jul 14. Adv Sci (Weinh). 2025. PMID: 40658067 Free PMC article.
Artificial intelligence algorithms for differentiating pseudoprogression from true progression in high-grade gliomas: A systematic review and meta-analysis.
Palavani LB, Nogueira BV, Mitre LP, Chen HC, Müller GC, Vilardo M, Pereira VG, Paleare LFF, Ribeiro FV, Araujo AAS, Ferreira MY, Varre H, Ferreira C, Paiva WS, Bertani R, D Amico RS, Neville IS. Palavani LB, et al. Among authors: chen hc. Neurosurg Rev. 2025 Aug 6;48(1):591. doi: 10.1007/s10143-025-03718-4. Neurosurg Rev. 2025. PMID: 40768078
Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials.
Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen HC, Pacheco-Barrios N, Ferreira MY, Batista S, Andreão FF, Polverini AD, Montenegro TS, Paiva W, Ferreira C, Bertani R, D'Amico RS. Palavani LB, et al. Among authors: chen hc. J Neurooncol. 2024 Dec;170(3):483-493. doi: 10.1007/s11060-024-04813-0. Epub 2024 Sep 4. J Neurooncol. 2024. PMID: 39230804 Review.
20 results